Priority Date: 19.12.11 (US 201161577289P)

RECOMBINANT HUMAN ALPHA-1-ANTITRYPSIN FOR THE TREATMENT OF INFLAMMATORY DISORDERS

  • Application ID: EP12859328
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 1999
Headquarter in Paris
active in Legal Services and IP Consulting

Specialization

This patent has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) Cabinet Becker & AssociƩs is specialized in A61. Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 19.12.2011 - Priority Date (US 201161577289P)
  • 27.06.2013 - Publication A1 (WO2013096458)
  • 29.10.2014 - Publication A1 (EP2793936)

IPC Classification